Share

    


Home / Search Results

Search Results

You searched for:

ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
Advocating on behalf of their patients and programs, ACCC members from 14 states participated in Virtual Hill Day, speaking with Congress and their staff on key legislation asks regarding access to care, telehealth, prior authorizations, and more.
ACCC is supporting the Improving Seniors’ Timely Access to Care Act of 2021, which would require Medicare Advantage plans to standardize and streamline prior authorization processes and increase the transparency of their requirements to prevent unnecessary denials and delays in patient care.
If passed, the Medical Nutrition Therapy Act could expand Medicare Part B to cover medical nutrition therapy services for patients with cancer, who need to maintain their strength and keep a health body weight during treatment. ACCCBuzz shares more about this legislation and why its benefits are essential for oncology.
At the end of last month, the Centers for Medicare & Medicaid Services (CMS) released the much-anticipated calendar year (CY) 2020 Medicare Payment rules. Touted by CMS as an effort to “empower patients with price transparency and increase competition to lower costs for Medicare beneficiaries,” the proposed Outpatient Prospective Payment System (OPPS) rule for 2020 introduces new price transparency …
Each year, in conjunction with the ACCC Annual Meeting and Cancer Center Business Summit, ACCC members come to Washington, D.C., for our Capitol Hill Day. Across the board, these members tell us how much they’ve enjoyed this unique opportunity to meet in small groups, or even one-on-one, with their legislators and congressional staffers to talk about challenges—and successes—at their cancer programs …
On October 25, 2018, President Trump addressed a campaign promise ahead of the heavily contested mid-term elections regarding his administration’s continued drug pricing reform efforts. Healthcare leadership under the Trump administration unveiled a three-prong plan using the Center for Medicare and Medicaid Innovation (CMMI) to test three ways to lower the costs of drugs, aimed largely at Medicare …
Autumn signals seasonal changes, but one constant is the annual assessment of the policy implications of the proposed Medicare payment rules for the upcoming calendar year. In this 2019 rule-making cycle, access to care and the overall reimbursement and healthcare delivery landscape have the potential to undergo a drastic shift. In September ACCC submitted comments to both the 2019 Physician Fee Schedule …
Nearly four months have passed since the Trump Administration released its blueprint for lowering drug prices. In the intervening time, there has been scrutiny of administration discussion on implementation of various proposals outlined in the plan. Most recently, during the month of August the Centers for Medicare & Medicaid Services (CMS) used its authority to the fullest, releasing two policy …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
Secretary Alex Azar has expressed strong interest in revitalizing Medicare’s Competitive Acquisition Program (CAP) and introducing negotiation into Part B drug pricing.